
About Triad Cornea
Triad Cornea is a company based in Winston-salem (United States) founded in 2018. It operates as a B2B. Triad Cornea operates in a competitive market with competitors including VSP Vision Care, Davis Vision and VSP Vision, among others.
- Headquarter Winston-salem, United States
- SectorsHealthcare
- Website triadcornea.org
Competitors of Triad Cornea
Triad Cornea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VSP Vision Care, Davis Vision and VSP Vision, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vsp.com | 1955 | Rancho Cordova, United States | – | – | VSP Vision Care provides vision insurance services to individuals and families. | |
| davisvision.com | 1917 | San Antonio, United States | – | 819 | Vision care insurance benefits are provided to members nationwide. | |
| vspvision.com | 1955 | Rancho Cordova, United States | – | – | Provides eye care services, eyewear solutions, and provider management support. |
Detailed competitors of Triad Cornea
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Triad Cornea
10 companies that operate in the same segment as Triad Cornea (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Triad Cornea
Triad Cornea was founded in 2018.
Triad Cornea is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
Triad Cornea offers cornea tissue distribution and reimbursement solutions for vision plans, focusing on providing healthcare solutions, medical services, ophthalmology, and tissue distribution. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Triad Cornea's top competitors include Davis Vision, VSP Vision Care and VSP Vision.